Literature DB >> 9252421

Dimerization of the highly conserved light chain shared by dynein and myosin V.

S E Benashski1, A Harrison, R S Patel-King, S M King.   

Abstract

The Mr 8,000 light chain originally identified in Chlamydomonas flagellar dynein is also a component of both cytoplasmic dynein and myosin V. Furthermore, this small protein has been implicated as an inhibitor of neuronal nitric oxide synthase, suggesting that it may play multiple regulatory roles within the cell. Covalent cross-linking of both dynein and myosin V using 1,5-difluoro-2, 4-dinitrobenzene revealed that this light chain exists as a dimer in situ. This observation was confirmed using two additional amine-selective cross-linking reagents (dimethyl pimelimidate and disuccinimidyl suberate). When expressed as a C-terminal fusion with maltose-binding protein, the presence of the light chain caused the recombinant molecule to dimerize. Analysis of fusions containing truncated light chains identified the predicted amphiphilic helix (residues 14-32) as sufficient to cause dimerization; cross-linking required a second helical segment (residues 33-46). Together the data presented suggest that two light chains interact to form a parallel dimeric structure. This arrangement has significant implications for the potential functions of this highly conserved molecule and suggests a mechanism by which it might dissociate nitric oxide synthase.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9252421     DOI: 10.1074/jbc.272.33.20929

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Cytoplasmic dynein LC8 interacts with lyssavirus phosphoprotein.

Authors:  Y Jacob; H Badrane; P E Ceccaldi; N Tordo
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Interaction of the rabies virus P protein with the LC8 dynein light chain.

Authors:  H Raux; A Flamand; D Blondel
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Subunit organization in cytoplasmic dynein subcomplexes.

Authors:  Stephen J King; Myriam Bonilla; Michael E Rodgers; Trina A Schroer
Journal:  Protein Sci       Date:  2002-05       Impact factor: 6.725

4.  Cellulose membrane supported peptide arrays for deciphering protein-protein interaction sites: the case of PIN, a protein with multiple natural partners.

Authors:  Anne-Dominique Lajoix; René Gross; Cindy Aknin; Samuel Dietz; Claude Granier; Daniel Laune
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

5.  Functional regulation of oestrogen receptor pathway by the dynein light chain 1.

Authors:  Suresh K Rayala; Petra den Hollander; Seetharaman Balasenthil; Zhibo Yang; Russell R Broaddus; Rakesh Kumar
Journal:  EMBO Rep       Date:  2005-06       Impact factor: 8.807

6.  Novel LC8 mutations have disparate effects on the assembly and stability of flagellar complexes.

Authors:  Pinfen Yang; Chun Yang; Maureen Wirschell; Stephanie Davis
Journal:  J Biol Chem       Date:  2009-08-19       Impact factor: 5.157

Review 7.  Structure-function-folding relationships and native energy landscape of dynein light chain protein: nuclear magnetic resonance insights.

Authors:  P M Krishna Mohan; Ramakrishna V Hosur
Journal:  J Biosci       Date:  2009-09       Impact factor: 1.826

8.  A Myosin Va mutant mouse with disruptions in glutamate synaptic development and mature plasticity in visual cortex.

Authors:  Akira Yoshii; Jian-Ping Zhao; Swarna Pandian; Brigitte van Zundert; Martha Constantine-Paton
Journal:  J Neurosci       Date:  2013-05-08       Impact factor: 6.167

9.  Localization of myosin-V in the centrosome.

Authors:  E M Espreafico; D E Coling; V Tsakraklides; K Krogh; J S Wolenski; G Kalinec; B Kachar
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

10.  Ebola virus VP35 interaction with dynein LC8 regulates viral RNA synthesis.

Authors:  Priya Luthra; David S Jordan; Daisy W Leung; Gaya K Amarasinghe; Christopher F Basler
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.